Interventional Pain Management has raised $58M in total funding. Latest round: Series D. Backed by Lightstone Ventures, ClavystBio, NEA.
Interventional Pain Management funding overview
Interventional Pain Management has raised $58M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in June 2025. The round record for Interventional Pain Management runs through 2025; nothing later has been disclosed. Investors on record include Lightstone Ventures, ClavystBio, NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare and 6 others. 12 distinct backers are named across the disclosed rounds.
Frequently asked about Interventional Pain Management funding
How much has Interventional Pain Management raised?
Interventional Pain Management has raised $58M in total disclosed funding across the rounds on record.
Who has invested in Interventional Pain Management?
Lightstone Ventures, ClavystBio, NEA, Arboretum Ventures, Vertex Growth, Vertex Ventures Healthcare are named among the investors backing Interventional Pain Management.
What was the latest Interventional Pain Management funding round?
The most recent disclosed round is a Series D, announced in June 2025.
Where is Interventional Pain Management based?
No headquarters location is disclosed for Interventional Pain Management.
When did Interventional Pain Management last raise?
The last disclosed Interventional Pain Management round closed in June 2025 at Series D.
Totals shown for Interventional Pain Management aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
Companies related to Interventional Pain Management (18)
